跳至主要内容
临床试验/CTRI/2021/05/033301
CTRI/2021/05/033301招募中未知

Prospective, multi center, observational, study on evaluation of use of, â??AyurCoro3â?? as an adjuvant for the treatment purpose in mild to moderate COVID-19 patients at tertiary care center. - Ayurcoro-3 Extension

Shri Sarveshwar Seva Sahkari Samstha0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Laboratory confirmed diagnosis of Mild to Moderate COVID-19 patients
  • 2.Patients in whom Ayurcoro-3 (as a adjuvant to the standard of care for mild to moderate covid-19) is prescribed by treating doctor.
  • 3.All Age groups above 18 Years
  • 4.All genders.

排除标准

  • 1.Patients on ventilator
  • 2.Critically ill patient
  • 3.Severe covid-19 patients (Dyspnea, respiratory frequency >= 30/min, Blood oxygen saturation (SpO2) <= 90%, PaO2/FiO2 ratio < 300, and/or lung infiltrates > 50% within 24 to 48 hours)
  • 4.Patients not willing to consent for the study.

研究者

发起方
Shri Sarveshwar Seva Sahkari Samstha

相似试验